Vivien E Prise Selected Research

iodoantipyrine

6/2009	Nitric oxide synthase inhibition enhances the tumor vascular-damaging effects of combretastatin a-4 3-o-phosphate at clinically relevant doses.
10/2002	The vascular response of tumor and normal tissues in the rat to the vascular targeting agent, combretastatin A-4-phosphate, at clinically relevant doses.
4/2002	Evaluation of the anti-vascular effects of combretastatin in rodent tumours by dynamic contrast enhanced MRI.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Vivien E Prise Research Topics

Disease

7	Neoplasms (Cancer) 12/2013 - 10/2002
3	Carcinosarcoma 05/2003 - 04/2002
2	Necrosis 12/2013 - 06/2009
2	Fibrosarcoma 12/2013 - 04/2008
1	Triple Negative Breast Neoplasms 04/2021
1	Breast Neoplasms (Breast Cancer) 04/2021
1	Sarcoma (Soft Tissue Sarcoma) 01/2008

Drug/Important Bio-Agent (IBA)

4	fosbretabulin (combretastatin A4)IBA 12/2013 - 04/2002
3	TubulinIBA 12/2013 - 04/2002
3	Protein Isoforms (Isoforms)IBA 12/2013 - 04/2008
3	iodoantipyrineIBA 06/2009 - 04/2002
2	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 12/2013 - 04/2008
2	fluorescein isothiocyanate dextranIBA 04/2008 - 01/2008
2	combretastatinIBA 01/2008 - 10/2002
1	NucleotidesIBA 04/2021
1	AnthracyclinesIBA 04/2021
1	Semaxinib (SU5416)IBA 12/2013
1	Vascular Endothelial Growth Factor Receptor-2 (Vascular Endothelial Growth Factor Receptor 2)IBA 12/2013
1	OxindolesIBA 12/2013
1	Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA 12/2013
1	Nitric Oxide Synthase (NO Synthase)IBA 06/2009
1	Nitroarginine (NG Nitro L Arginine)IBA 06/2009
1	Drinking WaterIBA 06/2009
1	Fluorescein-5-isothiocyanate (FITC)IBA 01/2008
1	Fluorescein (Funduscein)FDA LinkGeneric 01/2008
1	Dextrans (Dextran)FDA Link 01/2008
1	isothiocyanic acidIBA 01/2008
1	Contrast MediaIBA 01/2008
1	Antipyrine (Phenazone)FDA Link 05/2003
1	copper protoporphyrin IXIBA 05/2003
1	Proteins (Proteins, Gene)FDA Link 05/2003
1	tin protoporphyrin IXIBA 05/2003
1	BilirubinIBA 05/2003

Therapy/Procedure

3	Therapeutics 12/2013 - 01/2005
1	Drug Therapy (Chemotherapy) 04/2021
1	Lasers (Laser) 06/2009